Canada markets closed

Belite Bio Inc (D01.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
42.80-1.60 (-3.60%)
At close: 03:32PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
6,236
24,844
8,869
7,419
3,688
Selling General and Administrative
2,322
6,824
3,952
2,378
2,055
Total Operating Expenses
8,558
31,668
12,821
9,797
5,743
Operating Income or Loss
-8,558
-31,668
-12,821
-9,797
-5,743
Interest Expense
-
25
16
0
21
Total Other Income/Expenses Net
147
-4
166
126
-
Income Before Tax
-8,406
-31,623
-12,648
-9,666
-5,752
Income Tax Expense
0
9
0
0
1
Income from Continuing Operations
-8,406
-31,632
-12,648
-9,666
-5,753
Net Income
-8,406
-31,632
-12,648
-9,666
-5,753
Net Income available to common shareholders
-8,406
-31,632
-12,648
-9,666
-5,753
Basic EPS
-1.19
-1.19
-0.63
-0.40
-0.24
Diluted EPS
-1.19
-1.19
-0.63
-0.40
-0.24
Basic Average Shares
26,594
26,594
19,977
24,095
24,095
Diluted Average Shares
26,594
26,594
19,977
24,095
24,095